Training and Networking Working Group
The Training and Networking working group promotes training and networking throughout the GP2 project.
Learn more about Training and Networking Working Group
Is SH3GL2 p.G276V the Causal Functional Variant Underlying Parkinson’s Disease Risk at this Locus?
Meet the authors
PhD Student
Alejandra Lázaro-Figueroa
Universidad Nacional Autónoma de México | Mexico
MD, Research Fellow, Project Coordinator & MPS student
Ana Jimena Hernández-Medrano, MD
Instituto Nacional de Neurología y Neurocirugía | Mexico City, Mexico
Undergraduate Student
Diana Ramirez
UNAM, Laboratorio Internacional de Investigación sobre el Genoma Humano | Mexico
Unknown
Andres Navarro Cadavid
unknown | Colombia
Assistant Professor
Jia Nee Foo
Nanyang Technological University | Singapore
More outputs and publications
Towards a Global View of Parkinson's Disease Genetics
Description Parkinson\’s disease (PD) is a global health challenge, yet historically studies of PD have taken place predominantly in European populations. Recent genetics research conducted in non-European populations has revealed novel population-specific genetic loci linked to PD risk, highlighting the importance of studying PD globally. These insights have broadened our understanding of PD etiology, which […]
Mendelian Randomization and Parkinson's Disease
Description Integrative Omics in Parkinson’s Disease provides a comprehensive understanding of the current literature on high-throughput technologies relating to discoveries for Parkinson\’s disease etiology. This emerging field uses large omics datasets to investigate the etiology of Parkinson’s disease and other forms of parkinsonism. The book traces the evolution of omics technologies from the discovery of […]
Multi-ancestry population attributable risk assessment of common genetic variation in Alzheimer's and Parkinson's diseases
Description Multiple scientific studies, mostly performed within European populations, have unraveled many of the genetic factors associated with Alzheimer\’s disease (AD) and Parkinson\’s disease (PD) etiologies, improving our understanding of the molecular pathways implicated in the pathogenesis of these conditions. However, there is increasing evidence that the genetic architecture of these diseases differs across ancestral […]